Work

Safety, Pharmacokinetics, and Activity of GRN1005, a Novel Conjugate of Angiopep-2, a Peptide Facilitating Brain Penetration, and Paclitaxel, in Patients with Advanced Solid Tumors

Year: 2011

Type: article

Study design: Clinical Trial

Source: Molecular Cancer Therapeutics

DOI: 10.1158/1535-7163.mct-11-0566

Authors: Razelle Kurzrock, Nash Gabrail, Chandtip Chandhasin, Stacy Moulder, Carrie Smith, Andrew Brenner, Kamalesh Sankhala, Alain Mita, Kelly Elian, Danielle Bouchard, John Sarantopoulos

Institutions: The University of Texas MD Anderson Cancer Center, The University of Texas at San Antonio Health Science Center

Language: English

Topic: Nanoparticle-Based Drug Delivery

Subfield: Biomaterials

Field: Materials Science

Domain: Physical Sciences

SDG: Good health and well-being

Open Access status: closed

Funders: Johns Hopkins University, National Cancer Institute

Award: Mays Cancer Center at UT Health SA

OpenAlex ID: W2155576916

FWCI: 3.582

Cites: 21

Cited by: 178

Related to: 10